BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 10514129)

  • 1. Hepatomegaly and cholestasis as primary clinical manifestations of an AL-kappa amyloidosis.
    Mohr A; Miehlke S; Klauck S; Röcken C; Malfertheiner P
    Eur J Gastroenterol Hepatol; 1999 Aug; 11(8):921-5. PubMed ID: 10514129
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A rare case of cholestasis and macrohematuria in a 52-year-old patient].
    Arkenau HT; Widjaja A
    Med Klin (Munich); 2002 Aug; 97(8):480-3. PubMed ID: 12229247
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary systemic amyloidosis with giant hepatomegaly and a swiftly progressive course.
    Mainenti PP; Petrelli G; Lamanda R; Amalfi G; Castiglione F
    J Clin Gastroenterol; 1997 Apr; 24(3):173-5. PubMed ID: 9179738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. κ I light chain AL amyloidosis presenting with rapidly progressive renal and hepatic failure with unusual renal amyloid distribution.
    Oe Y; Nakaya I; Yahata M; Murata O; Yaegashi H; Sakuma T; Sato H; Liepnieks JJ; Benson MD; Soma J
    Clin Nephrol; 2012 Jan; 77(1):66-70. PubMed ID: 22185971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liver transplantation as rescue treatment in a patient with primary AL kappa amyloidosis.
    Nowak G; Westermark P; Wernerson A; Herlenius G; Sletten K; Ericzon BG
    Transpl Int; 2000; 13(2):92-7. PubMed ID: 10836644
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cholestatic jaundice and constitutional syndrome as early manifestations of primary systemic amyloidosis].
    Briceño HC; Galván C; Segarra M; Calduch JV; García A; Ribón F
    Gastroenterol Hepatol; 2003; 26(7):424-6. PubMed ID: 12887857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Light chain deposition disease of the liver associated with AL-type amyloidosis and severe cholestasis.
    Faa G; Van Eyken P; De Vos R; Fevery J; Van Damme B; De Groote J; Desmet VJ
    J Hepatol; 1991 Jan; 12(1):75-82. PubMed ID: 1901075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A case of prominent hepatic cholestasis developing to hepatic failure in lambda-AL amyloidosis.
    Dohmen K; Nagano M; Iwakiri R; Yamano Y; Kikuchi Y; Mizoguchi M; Iwata Y; Mori Y; Ishibashi H
    Gastroenterol Jpn; 1991 Jun; 26(3):376-81. PubMed ID: 1889693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Histological and immunohistochemical examinations in the diagnosis of hepatic amyloidosis].
    Mikhaleva LM; Gioeva ZV; Rёken K
    Arkh Patol; 2015; 77(4):11-16. PubMed ID: 26485775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [An unusual cause of hepatorenal symptoms].
    Frank H; Krammer M; Fierlbeck W; Riess R; Geiger H
    Med Klin (Munich); 1999 May; 94(5):274-8. PubMed ID: 10408189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of rapidly progressive liver light chain deposition under VAD chemotherapy in multiple myeloma.
    Samanez C; Domingo A; Cibeira MT; Miquel R; Soler M; Bladé J
    Eur J Haematol; 2006 Jan; 76(1):83-5. PubMed ID: 16343276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A case of kappa L-chain primary nodular lung amyloidosis].
    Kosacka M; Wojtala R; Piesiak P; Passowicz-Muszyńska E; Jankowska R
    Pol Merkur Lekarski; 2008 Dec; 25(150):516-8. PubMed ID: 19205385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vertebral compression fractures as the initial presentation of AL amyloidosis: case series and review of literature.
    Sarosiek S; Seldin DC; Connors LH; Spencer B; Murakami A; O'Hara C; Sanchorawala V
    Amyloid; 2015; 22(3):156-62. PubMed ID: 26104853
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary amyloidosis presenting as intrahepatic cholestasis.
    Bandyopadhyay SK; Bandyopadhyay R; Dutta A
    Indian J Pathol Microbiol; 2006 Oct; 49(4):557-9. PubMed ID: 17183853
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Primary amyloidosis of the gastrointestinal tract and liver--two case reports].
    Halm U; Berr F; Eggers E; Wohlgemuth B; Mössner J
    Z Gastroenterol; 1997 Feb; 35(2):131-7. PubMed ID: 9163226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The blue man: a novel cutaneous manifestation of systemic amyloidosis.
    Campbell M; Rosenthal A; Kundranda M; Pickert A; Dicaudo D; Dogan A; Mikhael J
    Amyloid; 2011 Sep; 18(3):156-9. PubMed ID: 21506660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cutaneous amyloidosis.
    Borowicz J; Gillespie M; Miller R
    Skinmed; 2011; 9(2):96-100; quiz 101. PubMed ID: 21548513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary systemic amyloidosis with giant hepatomegaly and portal hypertension: a case report and a review of the literature.
    Serra L; Poppi MC; Criscuolo M; Zandomeneghi R
    Ital J Gastroenterol; 1993 Oct; 25(8):435-8. PubMed ID: 8286779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The clinicopathological spectrum of renal amyloidosis.
    Hsu JY; Shu KH; Chan LP; Lu YS; Cheng CH; Sheu SS; Lian JD
    Zhonghua Yi Xue Za Zhi (Taipei); 1994 Oct; 54(4):230-9. PubMed ID: 7982133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amyloidosis of the tongue with kappa light chain disease.
    Basak PY; Ergin S; Sezer MT; Sari A
    Australas J Dermatol; 2001 Feb; 42(1):55-7. PubMed ID: 11233724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.